Reversible hepatic decompensation in primary biliary cirrhosis due to hypercoagulability.

doi:10.7326/0003-4819-147-9-200711060-00024

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Reversible hepatic decompensation in primary biliary cirrhosis due to hypercoagulability.

Annals of internal medicine - 6 Nov 2007

Lee Hannah M, Amin Manish, Kaplan Marshall M, Herlihy Edward F

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticoagulants
Share to Factor VIII
Share to Heterozygote
Share to Liver Cirrhosis, Biliary

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Liver Failure

Share to Mutation

Share to Thrombophilia

Share to Warfarin

Source

Open in PubMed

Identifiers

PMID: 17975196
DOI: 10.7326/0003-4819-147-9-200711060-00024

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Reversible hepatic decompensation in primary biliary cirrhosis due to hypercoagulability.PMID 17975196Read ↗

Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastography.Semantic proximity Read ↗

Anticoagulation in patients with liver cirrhosis: complication or therapeutic opportunity?Semantic proximity Read ↗

Increased factor VIII plays a significant role in plasma hypercoagulability phenotype of patients with cirrhosis.Semantic proximity Read ↗

Mechanisms of enhanced thrombin-generating capacity in patients with cirrhosis.Semantic proximity Read ↗

Rationale and targets for antifibrotic therapies.Semantic proximity Read ↗

Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment conceptsSemantic proximity Read ↗

Primary biliary cirrhosis in 2014.Semantic proximity Read ↗

Update on primary sclerosing cholangitis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.